BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2892864)

  • 1. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
    Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
    Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
    Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
    Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.
    Savarino V; Mela GS; Scalabrini P; Fera G; Zentilin P; Sumberaz A; Celle G
    Eur J Clin Pharmacol; 1988; 35(2):203-7. PubMed ID: 3191940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA; Lanzon-Miller S; Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Famotidine in gastric acidity, plasma secretin and gastrin in duodenal ulcer patients. With reference to 24-hour intragastric pH monitoring].
    Shiratori K; Watanabe S; Maruyama M; Itoh Y; Adachi H; Kurokawa K; Takeuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):855-63. PubMed ID: 6146733
    [No Abstract]   [Full Text] [Related]  

  • 10. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
    Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating duodenal ulcers.
    Okada M; Arita M; Iida M; Yao T; Sakurai T; Hoshiko K; Maeda K; Okada Y; Sakamoto K
    Gastroenterol Jpn; 1992 Apr; 27(2):179-86. PubMed ID: 1577222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
    Decktor D; Houle JM; Pierce CH
    Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.
    Merki HS; Witzel L; Kaufman D; Kempf M; Neumann J; Röhmel J; Walt RP
    Gut; 1988 Apr; 29(4):453-7. PubMed ID: 3286384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
    Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
    Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour intragastric pH-metry: H2-receptor antagonist restoration of nightly gastric spontaneous alkalinization in duodenal ulcer healing.
    Bianco A; Cagossi M; Piraccini R; Greco AV
    Riv Eur Sci Med Farmacol; 1992; 14(5):281-91. PubMed ID: 1364062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
    Savarino V; Mela GS; Zentilin P; Bonifacino G; Moretti M; Valle F; Celle G
    Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
    Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
    Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of single morning and single bedtime doses of famotidine on intragastric acidity in patients with gastric ulcer.
    Arita M; Okada M; Motomura A; Matsui T; Hosiko K; Yao T
    Am J Gastroenterol; 1994 Feb; 89(2):214-9. PubMed ID: 8304306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of acid suppression in H2-antagonist nonresponders.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Celle G
    Digestion; 1992; 51(4):185-92. PubMed ID: 1356863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.